Nancy E. Davidson, MD, discusses the future of HER2-targeted therapies in breast cancer.
Nancy E. Davidson, MD
Advertisement
Articles by Nancy E. Davidson, MD
Nancy E. Davidson, MD, shares how to leverage imaging technologies to inform treatment decisions in patients with breast cancer.
Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, on Screening for Ovarian Cancer
Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, Discusses Breast Cancer Chemoprevention
Advertisement
Latest Updated Articles
Dr. Davidson on the Future of HER2-Targeted Therapies in Breast CancerPublished: March 14th 2022 | Updated:
Dr. Davidson Discusses Breast Cancer ChemopreventionPublished: March 23rd 2012 | Updated:
Dr. Davidson on Screening for Ovarian CancerPublished: May 23rd 2012 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5